Kurt A. Schalper

PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

Andrea Cercek, Melissa Lumish, Jenna Sinopoli et al. · New England Journal of Medicine · 2022 · 1.4K citations · Full text

Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing

Hira Rizvi, Francisco Sánchez-Vega, Konnor La et al. · Journal of Clinical Oncology · 2018 · 1.4K citations · Full text

Immunology, Pathology, Immunotherapy +18

Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3

Jun Wang, Miguel F. Sanmamed, Ila Datar et al. · Cell · 2018 · 849 citations

Inflammation, Signal Transduction, Autoimmune Disease +10

Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer

Joseph McLaughlin, Gang Han, Kurt A. Schalper et al. · JAMA Oncology · 2015 · 828 citations · Full text

Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade

Ziming Wang, Ethan G. Aguilar, Jesus I. Luna et al. · Nature Medicine · 2018 · 806 citations

Obesity, Cancer Immunosurveillance, Pd-1 Checkpoint Blockade +10